Sidebar

Aiste Bulavaite  

Email: 

ORCID
ResearchGate

Research Interests: Studies on epidemiology and virulence factors of Gardnerella spp. Generation and characterization of recombinant viral and bacterial proteins in yeast and E.coli. 
Present Position: Researcher, Institute of Biotechnology, Life Sciences Center, Vilnius University 
Education:
2001 - BSc in Biology, Vilnius University
2003 - MSc in Biology, Vilnius University
2008 - PhD in Biochemistry, Vilnius University 
Experience (Past Positions): 2001–2003 Technician, Institute of Biotechnology
2007–2018 Research assistant, Institute of Biotechnology, Vilnius University
2018–present - Researcher, Institute of Biotechnology, Vilnius University
Publications: LABT_LMAVB PubMed

Projects and Grants:

Principal project implementer in the projects supported by the Research Council of Lithuania:
2020–2023 - Studies on the virulence potential of meningococcal isolates: implications for an improved molecular diagnostics of invasive meningococcal disease 01.2.2-LMT-K-718-03-0036.
2017–2020 - The prevalence and distribution of virulence factors among subgroups of vaginal bacteria Gardnerella vaginalis S-MIP-17-49.
2013–2015 - Synthesis of Schmallenberg Virus Proteins and Their Application for Diagnostic Means MIP-044/2013.
2012–2014 - High-Throughput Screening of Antibody-Secreting Cells Using Droplet-Based Microfluidics, MIP-048/2012.
2011–2012 - Analysis and diagnostics of new human Parvoviridea family viruses, MIP-060/2011.
2010–2011 - The analysis of distribution of gammaretrovirus XMRV and development of virus-specific antibody assay MIP-75/2010.
Principal implementer in the project supported by the Lithuanian Science and Study Foundation: 
2008–2010 - The role and diagnostics of rhinoviruses in the pathogenesis of allergic diseases B-37/2008.
Projects supported by European Comission:
2004–2009 - Framework 6: Rational design and standardized evaluation of novel genetic vaccines LSHB-2004-005246; participant.
2001–2006 - Framework 5: Combined immune and gene therapy for chronic viral hepatitis QLK2-2000-01476; participant.

Languages: Lithuanian, English, Russian

 

Cookies make it easier for us to provide you with our services. With the usage of our services you permit us to use cookies. More information